Embecta has agreed to acquire Owen Mumford Holdings for up to $172.6m, enhancing its global presence in drug delivery ...

Growing evidence has demonstrated that low-dose radiation can target inflammation and reduce pain for osteoarthritis patients ...

Nia Therapeutics' Smart Neurostimulation System (SNS) is the first device to obtain FDA breakthrough designation for memory loss related to moderate-to-severe traumatic brain injury (TBI).

The FDA PMA for JenaValve's Trilogy device for TAVR-AR comes months after a court struck down Edwards Lifesciences attempt to ...

KORU Medical has received the EU MDR certification for its Freedom60 infusion pump, including an adapter compatible with 50ml ...

LivaNova's aura6000 system delivers synchronised electrical pulses to the hypoglossal nerve to prevent airways collapse in OSA patients during sleep.

In data supporting FDA approval, 48.1% implanted with Prodeon’s Urocross saw International Prostate Symptom Score ...

Neuracle Technology has received marketing approval from China’s NMPA) for its invasive brain-computer interface (BCI) device ...

Paradromics initiative establishes alliances with leading BCI researchers at institutions including Stanford University with ...

GE HealthCare has received 510(k) clearance from the US FDA for View, the diagnostic viewer within its Genesis Radiology ...

With Amazon Health’s former chief medical officer recruited, the body scanning company is looking to grow beyond its European ...

GlobalData analysts highlight that the cyberattack could problematise Stryker’s supply chain and related business operations ...